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Abstract
Joubert syndrome (JS) and related disorders (JSRD) are a group of developmental delay/multiple congenital anomalies 
syndromes in which the obligatory hallmark is the molar tooth sign (MTS), a complex midbrain-hindbrain malformation 
visible on brain imaging, first recognized in JS. Estimates of the incidence of JSRD range between 1/80,000 and 1/
100,000 live births, although these figures may represent an underestimate. The neurological features of JSRD include 
hypotonia, ataxia, developmental delay, intellectual disability, abnormal eye movements, and neonatal breathing 
dysregulation. These may be associated with multiorgan involvement, mainly retinal dystrophy, nephronophthisis, 
hepatic fibrosis and polydactyly, with both inter- and intra-familial variability. JSRD are classified in six phenotypic 
subgroups: Pure JS; JS with ocular defect; JS with renal defect; JS with oculorenal defects; JS with hepatic defect; JS with 
orofaciodigital defects. With the exception of rare X-linked recessive cases, JSRD follow autosomal recessive inheritance 
and are genetically heterogeneous. Ten causative genes have been identified to date, all encoding for proteins of the 
primary cilium or the centrosome, making JSRD part of an expanding group of diseases called "ciliopathies". Mutational 
analysis of causative genes is available in few laboratories worldwide on a diagnostic or research basis. Differential 
diagnosis must consider in particular the other ciliopathies (such as nephronophthisis and Senior-Loken syndrome), 
distinct cerebellar and brainstem congenital defects and disorders with cerebro-oculo-renal manifestations. 
Recurrence risk is 25% in most families, although X-linked inheritance should also be considered. The identification of 
the molecular defect in couples at risk allows early prenatal genetic testing, whereas fetal brain neuroimaging may 
remain uninformative until the end of the second trimester of pregnancy. Detection of the MTS should be followed by 
a diagnostic protocol to assess multiorgan involvement. Optimal management requires a multidisciplinary approach, 
with particular attention to respiratory and feeding problems in neonates and infants. Cognitive and behavioral 
assessments are also recommended to provide young patients with adequate neuropsychological support and 
rehabilitation. After the first months of life, global prognosis varies considerably among JSRD subgroups, depending on 
the extent and severity of organ involvement.
Disease name and synonyms
The term Joubert Syndrome and Related Disorders
(JSRD) has been recently adopted to describe all disor-
ders presenting the "molar tooth sign" (MTS) on brain
imaging. Thus, JSRD include Joubert syndrome (JS, also
known as Joubert-Boltshauser syndrome
[OMIM#213300]), as well as any related condition show-
ing the MTS, such as the cerebello-oculo-renal syn-
drome, Dekaban-Arima syndrome [OMIM%243910],
COACH syndrome [OMIM216360], Varadi-Papp syn-
drome (or Orofaciodigital type VI, [OMIM%277170]),
Malta syndrome and a minority of cases with Senior-
Loken syndrome [OMIM#266900].
Definition and diagnostic criteria
Joubert syndrome (JS) was originally described in 1968 in
four siblings with agenesis of the cerebellar vermis pre-
senting episodic hyperpnoea, abnormal eye movements,
ataxia and intellectual disability [1]. Several years later, a
pathognomonic midbrain-hindbrain malformation, the
"molar tooth sign" (MTS), was detected first in JS [2], and
then in several other conditions previously considered as
distinct entities [3] (see section "Disease name and syn-
onyms"). The term "Joubert Syndrome and Related Disor-
ders" (JSRD) was then coined to group all conditions
sharing the MTS [4], and this neuroradiological sign now
represents the mandatory criterion to diagnose JSRD.
The MTS results from hypo-dysplasia of the cerebellar
vermis, abnormally deep interpeduncular fossa at the
level of the isthmus and upper pons, and horizontalized,
thickened and elongated superior cerebellar peduncles
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[5] (Figure 1). At the pathological level, these abnormali-
ties correspond to a picture of severe hypo-dysplasia of
the cerebellar vermis with midline clefting, fragmentation
of cerebellar nuclei and heterotopia of Purkinje-like neu-
rons, along with dysplasia of pontine and medullary
structures such as the basis pontis, reticular formation,
inferior olivary, dorsal column and solitary tract nuclei.
Moreover, typical findings are represented by the lack of
decussation both of the superior cerebellar peduncles and
of the corticospinal tracts at the medullary pyramids
[1,6].
JSRD are clinically heterogeneous and combine neuro-
logical signs with variable multiorgan involvement,
mainly of the retina, kidneys, liver and skeleton. This
marked pleiotropism can probably be explained by the
genetic basis of these syndromes. Ten causative genes
have been identified to date: JBTS1/INPP5E
[OMIM*613037], JBTS2/TMEM216  [OMIM*613277],
JBTS3/AHI1  [OMIM*608894], JBTS4/NPHP1  [OMIM*
607100], JBTS5/CEP290  [OMIM*610142], JBTS6/TME
M67  [OMIM*609884], JBTS7/RPGRIP1L  [OMIM*61
0937], JBTS8/ARL13B [OMIM*608922], JBTS9/CC2D2A
[OMIM*612013], JBTS10/OFD1  [OMIM*300170]. All
these genes encode for proteins of the primary cilium,
including JSRD in the group of "ciliopathies". Primary
cilia are known to play key roles in the development and
functioning of several cell types, including retinal photo-
receptors, neurons, kidney tubules and bile ducts [7,8]. In
the developing cerebellum and brainstem, these organ-
elles regulate major signal transduction pathways, and
have been implicated both in neuronal cell proliferation
and axonal migration [9].
JSRD present genetic and clinical overlap with other cil-
iopathies, in particular with Meckel syndrome, a lethal
malformative condition characterised by encephalocele,
other posterior fossa anomalies, ductal plate malforma-
tion of the liver and polycystic kidneys. JSRD and Meckel
syndrome phenotypes may represent the two ends of a
continuum and, indeed, mutations in at least five genes
(TMEM216,  CEP290,  TMEM67,  RPGRIP1L  and
CC2D2A) cause both disorders, with distinct mutation
types variably correlating with the phenotypic severity
[10-15]. Interestingly, preliminary genotype-phenotype
correlates indicate that Meckel syndrome fetuses nearly
invariably harbor truncating mutations, while at least one
hypomorphic (e.g. missense) mutation is found in almost
all JSRD cases [11,13,14].
Epidemiology
Although the incidence of JSRD has not been precisely
determined, it may range between 1/80,000 and 1/
100,000 live births, but may be underestimated [16,17].
Clinical description
Neurological features
The cardinal neurological features of JSRD are hypotonia
evolving into ataxia and developmental delay, often asso-
ciated with intellectual disability, altered respiratory pat-
tern in the neonatal period and abnormal ocular
movements [1,18-20].
Early hypotonia is observed in nearly all JSRD patients
a n d  c a n  b e  r e c o g n i z e d  i n  t h e  n e o n a t a l  p e r i o d  o r  i n
infancy. Although hypotonia represents an unspecific
finding of many neuropediatric disorders, its association
with other peculiar features such as an irregular breath-
ing pattern and altered eye movements should suggest
the diagnosis of JSRD and prompt the clinician to request
a brain magnetic resonance imaging. Patients often
develop ataxia with broad-based gait in the first years of
independent ambulation. These balance difficulties have
been extensively reviewed [2] and, although non-specific,
represent a frequent finding of JSRD. In some cases,
tremor has been reported [20].
The typical respiratory abnormalities are represented
by short alternate episodes of apnea and hyperpnea or
episodic hyperpnea alone, which tend to occur shortly
after birth, intensify with emotional stress and progres-
Figure 1 Brain MRI sections in patients with JSRD. A) mid-sagittal 
T1-weighted image shows a thin midbrain with corresponding en-
largement of the interpeduncular fossa (open arrowhead). There is 
concurrent superior vermian dysplasia (thin arrows); B) parasagittal T1-
weighted image shows thickened and maloriented superior cerebellar 
peduncle (thick arrowheads); C) axial T1-weighted image confirms the 
deepened interpeduncular fossa (open arrowhead) and abnormal su-
perior cerebellar peduncles (thick arrowheads), comprising the "molar 
tooth sign"; D) coronal FLAIR image shows midline cerebellar cleft 
(black arrows) indicating agenesis of the inferior vermis.Brancati et al. Orphanet Journal of Rare Diseases 2010, 5:20
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sively improve with age, usually disappearing around the
sixth month of life. Their severity can range from occa-
sional short-lasting episodes manifesting every few days
to extremely frequent (up to several per day) and pro-
longed attacks of apnea, requesting intensive care man-
agement and assisted ventilation [1,21].
Abnormal eye movements also represent a recurrent
feature in JSRD. Oculomotor apraxia is one of the most
characteristic and frequent abnormalities, that manifests
with the inability to follow objects visually with compen-
satory head movements, decreased smooth pursuit, and
cancellation of the vestibulo-ocular reflex. Primary posi-
tion nystagmus is also common, while occasionally asso-
ciated features include strabismus and ptosis. Such
manifestations are present independently from the spe-
cific defects of the eyes (see "Ocular features"), and relate
to the underlying midbrain-hindbrain malformation
[2,21-23].
Developmental abilities, in particular language and
motor skills, are delayed in all JSRD patients, with vari-
able degrees of severity [22,24-26]. Mild to severe intel-
lectual disability is common, with several patients being
able to attend special schools, learn specific job skills and
work in protected conditions [27]. However, it must be
stressed that intellectual deficit is not a mandatory fea-
ture of JSRD and exceptional cases may have borderline
or even normal intellect. Siblings discordant for this fea-
ture have been recently reported, further emphasizing
the difficulty to predict the neurological outcome in
infants [28,29].
A wide range of central nervous system (CNS) malfor-
mations are described in association to the MTS that can
dramatically affect the clinical outcome and prognosis of
patients with JSRD. These include hydrocephalus, cystic
enlargement of the posterior fossa, abnormalities of the
corpus callosum, white matter cysts, hypothalamic hama-
rtoma, and absence of the pituitary gland [30-38]. Abnor-
mal migration defects, mainly periventricular nodular
heterotopia, and cortical organization defects such as
polymicrogyria have also been reported [39,40]. Patients
with these malformations present a higher incidence of
epilepsy, which is otherwise a rare feature of JSRD
[32,39]. Finally, a small number of cases present with
occipital (meningo) encephalocele of variable severity
[1,34,41].
Ocular features
The retina is one of the organs most frequently involved
in JSRD, mostly in the form of retinal dystrophy, due to
progressive degeneration of photoreceptor cells. The
clinical spectrum can range from congenital retinal blind-
ness (also known as Leber congenital amaurosis - LCA),
to retinal dystrophy characterized by a progressive course
and variably conserved vision [2,42-45]. The diagnosis is
based on the findings of reduced visual acuity, associated
with abnormal fundus oculi and/or electroretinogram [3].
The association of LCA with nephronophthisis (NPH)
defines the Senior-Loken syndrome that, in a subset of
cases, also displays the MTS [3].
Colobomas can be unilateral or bilateral, and mostly
affect the posterior segment of the eye. Such defects orig-
inate from a failure in fetal fissure closure, which results
in colobomas involving the retinal pigmented epithelium,
the neurosensory retina or the choroids [46]. Iris colobo-
mas have been reported in few cases [3]. Colobomas rep-
r e s e n t  a  r a r e  c a u s e  o f  v i s u a l  i m p a i r m e n t  i n  a l l  J S R D
clinical subgroups, although their frequency reaches over
30% in the subgroup of JS with hepatic defect [47] (see
"Classification of JSRD").
Renal features
Renal disease affects approximately 25% of patients with
JSRD, presenting in most cases as NPH. This is a struc-
tural tubulo-interstitial disorder characterized by irregu-
lar, thickened basal membrane of the tubular epithelium
and progressive interstitial fibrosis, associated with small
cysts at the cortico-medullary junction. Juvenile NPH
may remain asymptomatic for several years or present
with subtle and often unrecognized signs such as polyuria
and polydypsia, until acute or chronic renal insufficiency
manifests in the late first or early second decade of life.
End stage renal failure is usually reached by the end of the
second decade, requiring dialysis or kidney transplanta-
tion. An infantile variant of NPH manifests within the
first years of life, with a more rapid and severe course
[48].
The association of MTS with cystic dysplastic kidney
(CDK), characterized by abnormal metanephric develop-
ment with macroscopically large kidneys and prominent
cysts, prompted some authors to delineate a novel clinical
entity termed Dekaban-Arima syndrome [OMIM
243910] [18,49,50]. However, a recent re-examination of
some of the originally reported patients showed histolog-
ical abnormalities more typical of NPH than of CDK,
challenging the existence of Dekaban-Arima syndrome
and suggesting that all JSRD present the same renal phe-
notype [51]. Of note, CDK is found in other ciliopathies
and typically in the lethal Meckel syndrome [52,53].
Hepatic features
A minority of JSRD patients present liver disease, usually
manifesting as congenital hepatic fibrosis (CHF). This
results from an embryonic malformation of the ductal
plate, with cystic dilatation of primitive biliary structures
and fibrous enlargement of the portal tracts [54]. Liver
disease may present with raised serum liver enzymes (ala-
nine aminotransferase, aspartate aminotransferase and
gamma-glutamyl transpeptidase) at least twice the nor-Brancati et al. Orphanet Journal of Rare Diseases 2010, 5:20
http://www.ojrd.com/content/5/1/20
Page 4 of 10
mal values, early onset hepato(spleno)megaly or more
severe manifestations including portal hypertension,
esophageal varices and liver cirrhosis [47,55].
The association of JS with CHF was previously known
by the acronym COACH (Cerebellar vermis hypoplasia,
Oligophrenia, Ataxia, Coloboma and Hepatic fibrosis)
[55,56].
Skeletal features
Since the description of the first JS family, polydactyly has
been often reported in JSRD with a frequency of about 8-
16% [1,18,57].
T h e  m o s t  c o m m o n  f o r m  i s  r e p r e s e n t e d  b y  p o s t a x i a l
polydactyly, variably affecting hands and feet [58]. The
association of JS with polydactyly and oral defects defines
a condition known as orofaciodigital type VI or Varadi-
Papp syndrome (OMIM 277170) [59]. In this case poly-
dactyly is typically mesaxial with Y-shaped metacarpals.
Mild to severe scoliosis may represent a manifestation
of JSRD and likely relates to the degree of hypotonia in
early infancy, while structural anomalies of the vertebrae
are uncommon [60].
Miscellaneous
Although JSRD are not typically dysmorphic syndromes,
patients have a characteristic face, and a recent study has
outlined the presence of peculiar craniofacial features
and distinct anthropometric facial patterns, which tend
to change with age [20,61]. Congenital heart defects are
n o t  t y p i c a l l y  a s s o c i a t e d  w i t h  J S R D  b u t  h a v e  b e e n
reported occasionally [62]. Laterality defects such as
complete situs inversus are also rare [63]. Hirschsprung's
disease has been described so far in two patients with
J S R D  [ 6 4 ] ,  b u t  i t s  f r e q u e n c y  i s  l i k e l y  t o  r e p r e s e n t  a n
underestimate. In fact, three individuals with
Hirschsprung's disease were observed in a cohort of
about 200 patients, suggesting that this association is not
coincidental (Brancati and Valente, unpublished observa-
tion). Interestingly, Hirschsprung's disease is associated
with another ciliopathy, Bardet-Biedl syndrome [65], and
cilia have been recently implicated in neural crest devel-
opment [66].
Classification of JSRD
The classification system of JSRD is still evolving due to
the discovery of novel genes and the improved under-
standing of genotype-phenotype correlations.
The MTS has been initially described as part of distinct
syndromes termed classical JS, JS plus LCA or retinal dys-
trophy, JS plus polymicrogyria, Senior-Loken, Dekaban-
Arima, COACH, Varadi-Papp, and Malta syndromes [4].
Although useful in the past, we now discourage the con-
tinued use of such eponyms in favor of a more practical,
clinical-genetic classification. The one proposed here
defines six subgroups based on the main organ(s)
involvement and the established genotype-phenotype
correlates (Table 1). Additional features such as facial
dysmorphism, polydactyly, colobomas, and other CNS
malformations (e.g. encephalocele, abnormal neuronal
migration, etc.) can be detected within all the following
subgroups.
Pure JS
In addition to the MTS, patients display the cardinal neu-
rological findings of hypotonia/ataxia and developmental
delay, variably associated with irregular breathing, abnor-
mal eye movements and intellectual disability. There is no
retinal, renal or liver involvement. No major gene has
been associated with this phenotype, but occasional
mutations in several genes have been reported [13,15,67-
73].
JS with ocular defect (JS-O)
The neurological features of JS are present in association
to retinal dystrophy (including LCA) with variable age at
onset, progression and severity. To date, the most fre-
quently mutated gene in this subgroup is AHI1, which
accounts for about 20% of cases [39,71,74,75].
JS with renal defect (JS-R)
In this subgroup, neurological signs are associated with
renal disease, which is in most cases juvenile NPH, in the
absence of retinal involvement. The two genes most com-
monly mutated in this rare phenotype are NPHP1 and
RPGRIP1L [11,76-80].
JS with oculorenal defects (JS-OR)
This form is characterized by the association of neurolog-
ical signs of JS with both retinal dystrophy and NPH.
About 50% of patients carry mutations in the CEP290
gene [10,81-83].
JS with hepatic defect (JS-H)
This subgroup presents the association of JS with CHF .
Chorioretinal or optic nerve colobomas and NPH can be
part of the phenotype but are not mandatory features.
Over 70% of cases are due to mutations in the TMEM67
gene [14,47,72,84,85].
JS with oro-facio-digital defects (JS-OFD)
In this subgroup, JS features are associated to bifid or lob-
ulated tongue (often described as soft-tissue nodules or
multiple hamartomas), multiple oral frenulae and poly-
dactyly, that is usually mesaxial, with Y-shaped metacar-
pals [4,59,86,87]. Hypothalamic hamartoma or congenital
absence of the pituitary gland can be part of this spec-
trum [38,86,88]. This phenotype has been recently asso-
ciated with mutations in the TMEM216 gene [15].Brancati et al. Orphanet Journal of Rare Diseases 2010, 5:20
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Diagnosis
A diagnosis of JSRD should be suspected in all infants
presenting with hypotonia, abnormal eye movements (in
particular oculomotor apraxia, but also nystagmus) and
developmental delay. The occurrence of abnormalities in
the respiratory pattern, i.e. hyperpneas alternating with
periods of apnea, reinforces the clinical suspicion of the
disease. In these children, a brain MRI is sufficient to
confirm or exclude the diagnosis, based on the detection
of the MTS (Figure 2).
Once a diagnosis of JSRD has been made, children
should enter a diagnostic protocol to assess the possible
multiorgan involvement. Ocular investigations include
evaluation of visual acuity, ocular motility, fundus oculi
and, whenever possible, electroretinogram. Slit lamp
examination can disclose abnormalities of the anterior
segment of the eye. Kidney and liver function should be
tested. Standard urine analysis is also necessary, and spe-
cial attention should be given to urine specific gravity;
should this value be abnormal or towards the lower nor-
mal range, a challenge test to assess urinary concentra-
tion ability is recommended. This is usually performed
with water restriction or, even better, by evaluating uri-
nary specific gravity after stimulation with Desmopres-
sin. Abdominal ultrasound will explore the kidneys (to
detect small cysts and loss of corticomedullar differentia-
tion, suggestive of NPH), and the liver (to identify
hepatomegaly or structural abnormalities that could
underlie CHF). If hepatic involvement is suspected, fur-
ther liver imaging techniques (such as magnetic reso-
Table 1: Classification of Joubert syndrome and related disorders based on associated clinical features
Clinical subtypes Mandatory 
features
Preferentially 
associated features*
Previously used 
nosology
Major gene(s)**
Pure Joubert syndrome (JS) MTS JS Mutations in many 
genes
JS type A
JS with ocular defect (JS-O) MTS
Retinal dystrophy 
(including LCA)
JS type B AHI1
JS with renal defect (JS-R) MTS NPHP1
NPH RPGRIP1L
MTS Cerebellooculorenal s.
JS with oculorenal defects 
(JS-OR)
Retinal dystrophy 
(often LCA)
(CHF reported in few 
cases)
SLS plus MTS CEP290
NPH JS type B
Dekaban-Arima s.
JS with hepatic defect (JS-H) MTS Colobomas COACH s. TMEM67
CHF NPH Gentile s.
JS with orofaciodigital 
defects (JS-OFD)
MTS Váradi-Papp s.
Lobulated/bifid 
tongue (incl. 
hamartomas)
Cleft lip/palate Orofaciodigital VI s. TMEM216 (2 
patients only)
Polydactyly
*Features not correlated with a specific clinical subtype include: postaxial polydactyly; encephalocele and other central nervous system 
malformations; neuronal migration defects (e.g. polymicrogyria); Hirschsprung's disease; congenital heart defects; laterality defects.
**Besides the major genes listed here, other genes have been occasionally associated with clinical subtypes. Mutations in the CC2D2A gene 
give rise to a wide phenotypic spectrum [13,73,85]. For INPP5E, ARL13B and OFD1 genes, only few mutated patients have been described to 
date [68-70]. Abbreviations: CHF: congenital hepatic fibrosis; incl.: including; JS: Joubert syndrome; LCA: Leber congenital amaurosis; MTS: 
molar tooth sign; NPH: nephronophthisis; s.: syndrome; SLS: Senior-Löken syndrome.Brancati et al. Orphanet Journal of Rare Diseases 2010, 5:20
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nance imaging) can support the diagnosis by
demonstrating bile ducts proliferation or fibrotic nod-
ules. Diagnosis is then confirmed by liver biopsy.
Possibly associated signs need to be investigated,
including pituitary defects, cleft palate, lobulated tongue,
congenital heart defects, situs inversus and Hirschsprung
disease. A careful assessment of brain imaging is also
requested to search for associated CNS malformations
(Figure 2).
To date, diagnostic genetic testing is available only for a
few genes, while selected laboratories offer molecular
testing of known genes on a research basis. Genes to be
tested should be prioritized by taking into account the
clinical subgroup to which the patient belongs and the
available genotype-phenotype correlates (Table 1).
Differential diagnosis
All conditions displaying neurological (hypotonia, abnor-
mal breathing, abnormal eye movements and develop-
mental delay) and/or organs manifestations seen in JSRD
(retinal dystrophy, NPH, CHF, polydactyly) should be
considered. In particular, these include other ciliopathies
such as isolated nephronophthisis, Senior-Loken syn-
drome and Bardet Biedl syndrome, as well as cerebellar
and brainstem congenital malformations and cerebro-
oculo-renal syndromes [48,89-91].
Genetic counseling and prenatal diagnosis
With the exception of rare cases following X-linked reces-
sive inheritance [70], JSRD are transmitted in autosomal
recessive fashion, and the recurrence risk for a couple
with an affected child is one in four. Prenatal diagnosis is
feasible through chorionic villus sampling at around
eleven weeks gestation, only in families in which the
molecular defect had been previously identified in the
proband. To date, published mutation screenings of
known genes have allowed the identification of mutations
in less than half JSRD patients, making prenatal diagnosis
still limited to a subset of families [92].
Figure 2 Schematic approach to the diagnosis and management of JSRD. Left: clinical manifestations that - in variable association - may lead to 
the diagnostic suspicion of JSRD. Middle: the detection of the MTS by brain magnetic resonance imaging confirms the diagnosis; in a subset of pa-
tients, other CNS defects may be identified. Right: proposed evaluation protocol for multiorgan involvement. *by water restriction or Desmopressin 
test.Brancati et al. Orphanet Journal of Rare Diseases 2010, 5:20
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In the remaining families, fetal ultrasound may be use-
ful in at-risk pregnancies, allowing the detection of hyp-
oplasia of the cerebellar vermis and, when present,
occipital encephalocele. Polydactyly may also represent a
suggestive, although non-specific, feature possibly associ-
ated with all JSRD phenotypes [93,94]. Recently, fetal
MRI has been acknowledged as the method of choice to
delineate posterior fossa malformations, facilitating the
diagnosis of the disease before 24 weeks of gestation [95-
97].
Management and follow-up
In neonates and infants particular care should be taken in
managing respiratory and feeding problems related to
either breathing abnormalities or hypotonia. Rehabilita-
tion strategies must be planned for cognitive and behav-
ioral difficulties and specific manifestations such as the
visual impairment.
Any abnormal feature identified during the diagnostic
assessment should be carefully followed up over time. In
particular, the detection of decreased urinary concentra-
tion ability often represents the first clue to a diagnosis of
NPH in otherwise asymptomatic patients. This requires a
close monitoring to timely recognize and treat early signs
of renal failure and to delay the onset of complications
such as growth defect or bone disease. If CHF is diag-
nosed, specific follow-up should be planned to manage
possible complications, including portal hypertension
and esophageal varices.
Prognosis
Soon after birth, prognosis is related to the extent and
severity of breathing dysregulation. In particular, recur-
rent episodes of prolonged apneas can be life-threatening
and require assisted ventilation. In most cases, these
respiratory abnormalities resolve spontaneously in the
first months or years of life. Feeding difficulties may rep-
resent a problem in a number of patients. Afterwards,
prognosis depends mostly on renal and hepatic complica-
tions that, if not timely diagnosed and managed, repre-
sent the major causes of death in JSRD patients.
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